Login / Signup

Feasibility of analyzing DNA copy number variation in breast cancer tumor specimens from 1950 to 2010: how old is too old?

Nancy KriegerSheida NabaviPamela D WatermanNinah S AchacosoLuana ActonStuart J SchnittLaurel A Habel
Published in: Cancer causes & control : CCC (2018)
Assays conducted in the mid-2010s for CNVs may be feasible for FFPE tumor specimens dating back to the 1980s, but less feasible for older specimens.
Keyphrases
  • copy number
  • mitochondrial dna
  • genome wide
  • fine needle aspiration
  • high throughput
  • physical activity
  • middle aged
  • gene expression
  • ultrasound guided
  • breast cancer risk